FDA Inspects Slovene Pharmaceutical Company
Ljubljana, 15 July - The U.S. Food and Drug Administration (FDA) inspected plants for the production of the amoxyclav antibiotic of Slovene pharmaceutical company Lek between 17 June and 4 July. Lek is very satisfied with the results of the inspection, as the FDA report revealed no discrepancies in the inspected segments of the production.
The rest of this news item is available to subscribers.
The news item consists of 478 characters (without spaces) or 83 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.